Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
More Evidence That HIV-Negative Gays Contract Hep C Via Sex

Increasing evidence suggests that hepatitis C transmits sexually among HIV-negative men who have sex with men, and not just among HIV-positive MSM.

Published
26 December 2014
From
AIDSMeds
Even with New AbbVie Drug, Many Hepatitis C Patients Are Being Turned Away from Treatment

Even with New AbbVie Drug, Many Hepatitis C Patients Are Being Turned Away from Treatment. Doctors, insurance companies, and even governments have cried foul over high prices the new medications Sovaldi, Harvoni, and now Viekira Pak. Sick people aren’t getting the treatments they need due to insurance denials and other roadblocks.

Published
23 December 2014
From
Hepatitis C News
Gilead slides after hepatitis drug setback

Gilead Sciences shares backtracked from their giddy ascent of the past three years, falling more than 10 per cent after the company’s flagship hepatitis C treatment fell out of favour with the largest pharmacy benefits manager in the US. High quality global journalism requires investment. Express Scripts, which helps manage the cost of healthcare plans offered by companies as well as some government programmes, said it had chosen Viekira Pak, a medicine developed by drugmaker AbbVie, as the “exclusive option” for patients.

Published
23 December 2014
From
Financial Times (free registration required)
New open-access journal in the rapidly developing field of virus eradication

The Journal of Virus Eradication is a new open-access online and print journal dedicated to the rapidly developing field of virus eradication. It is particularly interested in publishing original research on HIV, hepatitis viruses, HPV, herpes and flu but work on other viruses is also included. The first issue was successfully launched at the HIV and Hepatitis Five Nations Conference in London on 8 December 2014 and is available now on the Journal website: www.viruseradication.com

Published
23 December 2014
From
Mediscript
Entecavir and tenofovir work well for people with drug-resistant hepatitis B virus

A combination of entecavir plus tenofovir effectively suppressed hepatitis B virus (HBV) in people with resistance to other antivirals, according to results from the European ENTEBE study

Published
22 December 2014
By
Liz Highleyman
Hepatitis C patients stage sit-in to demand access to new treatment

Protest at Madrid hospital aims to shame the government into releasing more funds.

Published
20 December 2014
From
El Pais
US FDA approves AbbVie hepatitis C drug, costs $83319 for 12 weeks

U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, and the company said the drug would cost $83,319 for a typical 12-week plan, a bit below its huge selling competitor Sovaldi from Gilead Sciences.

Published
20 December 2014
From
Reuters
Preventing hepatitis C patients from being lost in the health-care system

A new study shows that many patients infected with the hepatitis C virus (HCV) are lost during different stages of health care to manage the disease. This real-life' view of the HCV patient care continuum in a major U.S. urban area highlights the importance of generating awareness among clinicians and at-risk groups about appropriate HCV testing, referral, support and care.

Published
19 December 2014
From
Eurekalert Inf Dis
One million people with hepatitis C in the US at high priority for treatment

An estimated 813,000 people with diagnosed hepatitis C in the US have undergone liver disease staging and meet the 'highest' or 'high' priority criteria for immediate treatment, according

Published
18 December 2014
By
Liz Highleyman
Many hepatitis C patients with cirrhosis or advanced fibrosis face liver failure and liver cancer

Nearly one-third of chronic hepatitis C patients with liver cirrhosis and 12% with advanced fibrosis progressed to decompensation within five years, and 23% and 11%, respectively, died, according

Published
18 December 2014
By
Liz Highleyman
← First12345...152Next →

Filter by country